Caroline Berenguer‐Daizé
Centre National de la Recherche Scientifique(FR)Centre National de la Recherche Scientifique(FR)Aix-Marseille Université(FR)Institut de Neurophysiopathologie(FR)
Publications by Year
Research Areas
Neuropeptides and Animal Physiology, Cancer, Stress, Anesthesia, and Immune Response, Receptor Mechanisms and Signaling, Peptidase Inhibition and Analysis, Inflammatory mediators and NSAID effects
Most-Cited Works
- → OTX015 (MK‐8628), a novel BET inhibitor, displays in vitro and in vivo antitumor effects alone and in combination with conventional therapies in glioblastoma models(2016)150 cited
- → Stromal fibroblasts present in breast carcinomas promote tumor growth and angiogenesis through adrenomedullin secretion(2017)62 cited
- → Adrenomedullin Blockade Suppresses Growth of Human Hormone–Independent Prostate Tumor Xenograft in Mice(2013)50 cited
- → Adrenomedullin promotes cell cycle transit and up-regulates cyclin D1 protein level in human glioblastoma cells through the activation of c-Jun/JNK/AP-1 signal transduction pathway(2009)43 cited
- → Targeting Adrenomedullin in Oncology: A Feasible Strategy With Potential as Much More Than an Alternative Anti-Angiogenic Therapy(2021)32 cited
- → Adrenomedullin blockade induces regression of tumor neovessels through interference with vascular endothelial-cadherin signalling